Source comparisons
Approved comparison material connected to this topic. Only stored records are displayed.
Comparison
GHK-Cu (copper tripeptide) Stimulating dermal papilla cells, prolonging/enlarging follicles, and raising VEGF signalling in lab and rodent models Preclinical (in-vitro human follicle + mouse); no monotherapy RCT Human d…
Source: dosagepeptide.comComparison
GHK-Cu (Copper Peptide) Activates Wnt/β-catenin pathway; increases dermal papilla cell proliferation by 230% Topical solution (1–5 mM) 1 mL daily to affected areas 12–16 weeks Strongest topical evidence. Low side effect…
Source: realpeptides.coComparison
GHK-Cu vs BPC-157 compared: mechanisms, evidence, dosage, and when to use each. One has human clinical data, the other has broader preclinical reach.
Source: peptidepedia.orgComparison
Most well-formulated scalp copper peptide products contain GHK-Cu. The distinction matters mainly for protocol design: if using a standalone GHK-Cu serum, the considerations above apply. If using a copper peptide comple…
Source: peptidepedia.org